ACTU peer analysis
Actuate Therapeutics (ACTU) against its competitors: price, today's move, 1-year return and market value side by side.
- ACTU's peers: ALEC (Alector), ELTX (Elicio), MCRB (Seres Therapeutics), MOLN (Molecular Partners), NKTX (Nkarta), PEPG (PepGen), SPRO (Spero Therapeutics), VOR (Vor Biopharma).
ACTU and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALEC Alector | $2.33 | 1.52% | 91.39% | $347.63M |
| ELTX Elicio | $1.50 | -5.66% | -81.48% | $42.46M |
| MCRB Seres Therapeutics | $1.33 | -7.64% | -95.35% | $13.56M |
| MOLN Molecular Partners | $2.67 | -6.82% | – | $102.16M |
| NKTX Nkarta | $1.15 | 2.68% | -35.75% | $82.37M |
| PEPG PepGen | $3.79 | -3.56% | -31.46% | $262.50M |
| SPRO Spero Therapeutics | $0.83 | -5.46% | -65.28% | $48.14M |
| VOR Vor Biopharma | $19.20 | 3.67% | 145.52% | $1.18B |
| VTGN Vistagen Therapeutics | $0.19 | -6.47% | -95.85% | $8.62M |
| ACTU Actuate Therapeutics | $0.21 | -12.95% | -96.35% | $5.13M |